Overview of Biliary Tract Cancer & Importance of Targeted Therapies

Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain are joined by Dr. Ghassan Abou-Alfa, a medical oncologist specializing in the hepatobiliary space at Memorial Sloan Kettering. Together, they explored the current treatment landscape of biliary tract cancer, focusing on the advancements in HER2-driven therapies.Key topics discussed included:• The evolution of treatment options for biliary tract cancer, including chemotherapy and immunotherapy.• The significance of genetic testing, including IDH1 mutations, FGFR alterations, and HER2 status.• The role of multidisciplinary collaboration in managing hepatobiliary cancers.• Insights into the latest clinical trials and emerging therapies for HER2-positive biliary tract cancer.Join us as we delve into the complexities of biliary tract cancer and the promising developments in HER2-targeted treatments. Don't forget to check out our next episode, where we will take a deeper dive into the data surrounding HER2 therapies and discuss management strategies for common side effects.YouTube: https://youtu.be/pGiU7JJGNOcFollow us on social media:•⁠  ⁠X/Twitter: https://twitter.com/oncbrothers•⁠  ⁠Instagram: https://www.instagram.com/oncbrothers•⁠  Website: https://oncbrothers.com/Subscribe to stay updated on the latest in oncology!#OncologyBrothers #BiliaryTractCancer #HER2 #CancerTreatment #MedicalOncology #CME #Podcast